News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Valeant Pharmaceuticals International
NEWS
IN THE PRESS
NEWS
Valeant Pharmaceuticals International was acquired by Bausch & Lomb in 2013.
Business
Valeant Severs Ties With Controversial Specialty Pharmacy Philidor, Which Plans to Shutter its Doors
October 30, 2015
·
4 min read
Deals
While Regulators Investigate, Valeant Eyes the Contact Lens Market
October 29, 2015
·
4 min read
Policy
More Scandal Clouds Valeant as Committee is Formed to Review Accounting Practices; Conference Call to be Held Today
October 26, 2015
·
4 min read
Pharm Country
Martin Shkreli Tweets He Has Taken a “Long Position” on Valeant Stock
October 23, 2015
·
3 min read
Policy
Valeant Plunges After Bearish Report Likens it to Enron
October 21, 2015
·
4 min read
Deals
Valeant Mulls Divesture of Neurology Business Following Criticism Over Pricing, Business Practices
October 20, 2015
·
3 min read
Job Trends
Valeant’s Bausch & Lomb Adding 200 Jobs in $150 Million Expansion of South Carolina Plant
October 16, 2015
·
3 min read
Policy
Valeant Investigated By Feds for Its Drug Pricing Practices; Faces Multiple Subpoenas
October 15, 2015
·
3 min read
Valeant Fires Back at Critics, Supported by Investor Bill Ackman
October 7, 2015
·
3 min read
IN THE PRESS
Business
Valeant Announces Collaboration Between Bausch & Lomb And IBM
May 5, 2016
·
3 min read
Business
Joseph C. Papa Officially Takes Over as Chairman And CEO of Valeant
May 3, 2016
·
2 min read
Business
Valeant Seeks Fresh Start with Board Shakeup
May 2, 2016
·
7 min read
Valeant Receives Additional Notices Of Default Under Indentures Due To Delayed 10-K Filing
April 25, 2016
·
3 min read
Policy
Valeant Provides Update Regarding Regulatory Matters
April 14, 2016
·
3 min read
Business
Valeant Board Of Directors Issues Statement On J. Michael Pearson’s Cooperation With Senate Committee On Aging
April 11, 2016
·
2 min read
Valeant Receives Lender Consent For Credit Facility Amendment
April 7, 2016
·
3 min read
Policy
Valeant Ad Hoc Committee Announces Completion Of Its Review Of Philidor And Related Accounting Matters
April 5, 2016
·
3 min read
Policy
FDA Extends Action Date for Progenics, Valeant’s NDA for Oral RELISTOR
April 4, 2016
·
4 min read
Valeant Launches Credit Facility Amendment
March 30, 2016
·
3 min read
